$2.69 +0.06 (2.28%) Rigel Pharmaceuticals Inc - NASDAQ

Dec. 9, 2016 | 04:00 PM

Charts

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Key Statistics
Last Trade: 2.69
Trade Time: Dec 09 04:00 PM Eastern Daylight Time
Change: +0.06 (2.28%)
Prev Close: 2.63
Open: 2.65
Bid: 2.68
Ask: 2.69

Competitors

Ticker Name Volume % Change
THLD Threshold Pharmaceuticals Inc. 3.38M +21.40%
PDLI PDL BioPharma Inc. 2.81M +1.82%
NKTR Nektar Therapeutics 1.98M +2.55%
DNAI ProNAi Therapeutics 1.70M +5.92%
SGMO Sangamo BioSciences Inc. 1.60M +18.52%

RIGL Stock Analysis

Partner Headlines

  1. Rigel Completes Enrollment of First Phase 3 Study of Fostamatinib in ITP

    Benzinga | Jan. 28, 2016 | 07:37AM EST
  2. Rigel Granted Orphan Drug Designation for Fostamatinib in ITP

    Benzinga | Sep. 8, 2015 | 06:30AM EST
  3. Earnings Scheduled For March 3, 2015

    Benzinga | Mar. 3, 2015 | 04:18AM EST
  4. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  5. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) ...

    GuruFocus | Feb. 23, 2015 | 14:58PM EST
  6. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST